Enzyme vs Orbiter Finance — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Orbiter Finance trades at Rp5.08 (market cap Rp29,02M, Rp14M 24h volume). The key difference: Enzyme is far larger — about 4.6× Orbiter Finance's market cap, and Orbiter Finance's supply is capped (5,7B / 10B OBT (58%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and Orbiter Finance for 12 Days on average.
| MLN | OBT | |
|---|---|---|
Market Cap | Rp134,13M | Rp29,02M |
Volume (24h) | Rp104,56M | Rp14M |
Circulating Supply | 3,3M MLN | 5,7B / 10B OBT (58%) |
Typical Hold Time | 29 Days | 12 Days |
What Pluang investors did over the last 30 days
No sentiment data available yet.
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →Orbiter Finance is an interoperability blockchain infrastructure based on zero-knowledge technology (ZK-tech). It aims to enhance the security of blockchain interactions, ensure seamless interoperability, and reduce liquidity fragmentation. Orbiter achieves this through innovative solutions, including a universal cross-chain protocol and Omni Account Abstraction. Its goal is to redefine the Web3 experience in the multichain era.
Read more on OBT →